abbott-laboratories

Abbott pulls obesity drug from US market (AFP)

AFP – US pharmaceutical company Abbott Laboratories on Friday said it was pulling its obesity drug Meridia from the US market after European tests found the key ingredient increased the risk of serious heart problems.

Here is the original:
Abbott pulls obesity drug from US market
(AFP)

abbott-laboratories

Weight-Loss Drug Meridia Pulled From U.S. Market (HealthDay)

HealthDay – FRIDAY, Oct. 8 (HealthDay News) — The obesity drug Meridia has been withdrawn from the U.S. market because of an increased risk of heart attack and stroke, federal health officials said Friday.

Go here to see the original: 
Weight-Loss Drug Meridia Pulled From U.S. Market
(HealthDay)

abbott-laboratories

Diet pills contain unlisted stimulant, US agency warns (AFP)

AFP – The US Food and Drug Administration (FDA) on Friday warned consumers not to use a brand of weight loss pills that claim to be “100 percent herbal” after lab tests showed they contain a dangerous stimulant.

Read the original: 
Diet pills contain unlisted stimulant, US agency warns
(AFP)

abbott-laboratories

Health officials pull Abbott’s Meridia diet drug off market (Reuters)

Reuters – U.S. health officials have ordered Abbott Laboratories’ controversial weight loss drug Meridia off the market, and the company said it would comply even though it still thinks the drug is safe.

Excerpt from:
Health officials pull Abbott’s Meridia diet drug off market
(Reuters)

abbott-laboratories

U.S. panel splits on Abbott diet drug ban (Reuters)

Reuters – A U.S. advisory panel was divided over whether to recommend banning Abbott Laboratories’ controversial weight-loss drug on Wednesday, although most agreed that the drug’s heart risk cast a shadow on its future use.

Original post:
U.S. panel splits on Abbott diet drug ban
(Reuters)

abbott-laboratories

Abbott diet drug faces U.S. fight to stay on market (Reuters)

Reuters – Amid a battle to reshape the nearly $400 million obesity drug sector, Abbott Laboratories faces a critical test on Wednesday over whether its controversial diet pill should remain on the U.S. market, despite heart risks.

See original here:
Abbott diet drug faces U.S. fight to stay on market
(Reuters)

abbott-laboratories

FDA to ask panel whether to ban Abbott diet drug (Reuters)

Reuters – U.S. health regulators could pull Abbott Laboratories controversial weight-loss drug Meridia off the market over heart problems, according to documents released on Monday.

Go here to read the rest: 
FDA to ask panel whether to ban Abbott diet drug
(Reuters)

abbott-laboratories

Abbott diet drug study renews calls for U.S. ban (Reuters)

Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

Originally posted here:
Abbott diet drug study renews calls for U.S. ban
(Reuters)

abbott-laboratories

Abbott’s diet drug study renews calls for U.S. ban (Reuters)

Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

Original post:
Abbott’s diet drug study renews calls for U.S. ban
(Reuters)